181 related articles for article (PubMed ID: 9659297)
21. Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-beta-arrested Mv1Lu cells.
Taipale M; Tiihonen E; Heiskanen A; Laiho M
Exp Cell Res; 2000 Aug; 259(1):107-16. PubMed ID: 10942583
[TBL] [Abstract][Full Text] [Related]
22. Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas.
Kawamata N; Seriu T; Koeffler HP; Bartram CR
Cancer; 1996 Feb; 77(3):570-5. PubMed ID: 8630967
[TBL] [Abstract][Full Text] [Related]
23. Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer.
Shin JY; Kim HS; Lee KS; Kim J; Park JB; Won MH; Chae SW; Choi YH; Choi KC; Park YE; Lee JY
Exp Mol Med; 2000 Jun; 32(2):79-83. PubMed ID: 10926119
[TBL] [Abstract][Full Text] [Related]
24. Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1).
Wang G; Miskimins R; Miskimins WK
Exp Cell Res; 2000 Jan; 254(1):64-71. PubMed ID: 10623466
[TBL] [Abstract][Full Text] [Related]
25. p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma.
Fornaro M; Tallini G; Zheng DQ; Flanagan WM; Manzotti M; Languino LR
J Clin Invest; 1999 Feb; 103(3):321-9. PubMed ID: 9927492
[TBL] [Abstract][Full Text] [Related]
26. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
[TBL] [Abstract][Full Text] [Related]
27. Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer.
Sgambato A; Ratto C; Faraglia B; Merico M; Ardito R; Schinzari G; Romano G; Cittadini AR
Mol Carcinog; 1999 Nov; 26(3):172-9. PubMed ID: 10559792
[TBL] [Abstract][Full Text] [Related]
28. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus.
Mann DJ; Child ES; Swanton C; Laman H; Jones N
EMBO J; 1999 Feb; 18(3):654-63. PubMed ID: 9927425
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of cyclin D1, cyclin E and p21(Cip1) associated with decreased expression of p27(Kip1) in chemically induced rat mammary carcinogenesis.
Jang TJ; Kang MS; Kim H; Kim DH; Lee JI; Kim JR
Jpn J Cancer Res; 2000 Dec; 91(12):1222-32. PubMed ID: 11123420
[TBL] [Abstract][Full Text] [Related]
30. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).
Cheng M; Sexl V; Sherr CJ; Roussel MF
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1091-6. PubMed ID: 9448290
[TBL] [Abstract][Full Text] [Related]
31. Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice.
Poolman RA; Li JM; Durand B; Brooks G
Circ Res; 1999 Jul; 85(2):117-27. PubMed ID: 10417393
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
[TBL] [Abstract][Full Text] [Related]
33. The p27/Kip1 locus shows no loss of heterozygosity in human pituitary adenomas.
Wilson JC; Zhu JJ; Black PM
J Neurooncol; 1999 Aug; 44(1):35-9. PubMed ID: 10582666
[No Abstract] [Full Text] [Related]
34. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.
Schrantz N; Beney GE; Auffredou MT; Bourgeade MF; Leca G; Vazquez A
J Immunol; 2000 Oct; 165(8):4346-52. PubMed ID: 11035070
[TBL] [Abstract][Full Text] [Related]
35. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of p21 and p27 genes in human pituitary adenomas.
Ikeda H; Yoshimoto T; Shida N
Br J Cancer; 1997; 76(9):1119-23. PubMed ID: 9365157
[TBL] [Abstract][Full Text] [Related]
37. Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1).
Hiromura K; Pippin JW; Fero ML; Roberts JM; Shankland SJ
J Clin Invest; 1999 Mar; 103(5):597-604. PubMed ID: 10074476
[TBL] [Abstract][Full Text] [Related]
38. Cyclin E-mediated elimination of p27 requires its interaction with the nuclear pore-associated protein mNPAP60.
Müller D; Thieke K; Bürgin A; Dickmanns A; Eilers M
EMBO J; 2000 May; 19(10):2168-80. PubMed ID: 10811608
[TBL] [Abstract][Full Text] [Related]
39. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
[TBL] [Abstract][Full Text] [Related]
40. Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence.
Alexander K; Hinds PW
Mol Cell Biol; 2001 Jun; 21(11):3616-31. PubMed ID: 11340156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]